CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients with normal pressure hydrocephalus (NPH). At the 90-day primary endpoint of ...

Figure 2: Development and noninvasive treatment of bilateral subdural hygromas following placement of a programmable shunt for idiopathic normal pressure hydrocephalus. Although CSF shunting is a ...

Based on these clinical findings, I plan to pursue further research to facilitate the practical application of ultrasound treatment for patients with normal pressure hydrocephalus.” Lee Dong ...

"CereVasc scores safety and efficacy win in hydrocephalus treatment pilot study" was originally created and published by Medical Device Network, a GlobalData owned brand.

The next step in treating Mr. M was to attempt to determine his responsiveness to ventriculoperitoneal (VP) shunting (Fig 2). Although VP shunting is prone to complications and not appropriate for ...

The classic triad of symptoms gait disturbance, cognitive dysfunction, and urinary incontinence generally responds to treatment if present for less than 2 years' duration. Gait and balance ...

Background Hydrocephalus is a significant contributor to morbidity following aneurysmal subarachnoid hemorrhage (aSAH). We aimed to investigate the association between primary treatment modality and ...

The hydrocephalus shunt market is experiencing rapid innovation, with newer, more efficient shunt systems being introduced to the market. These advancements are improving patient outcomes and catering ...

WHEN a 44-year-old man began experiencing a common symptom experienced by millions, he decided to get checked out by medical ...

18.In case you want nightmares, it turns out it's possible to GROW A WISDOM TOOTH NEAR YOUR EYE SOCKET. 21.Here's what it looks like to have a split hand malformation, or Ectrodactyly, a rare genetic ...